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Supporting Figure 1.  a) Boc-Py-OBt (1), DIEA, DMF, 80 ºC, microwave, 3 h; b) 80:1:19 TFA:triethylsilane: 
CH2Cl2 (v/v/v), 5 mins, RT; c) Boc-Py-OBt, DIEA, DMF, 60 ºC, microwave, 5 mins; d) Ac2O, DIEA, DMF, RT, 10 
min; e) repeat b)-d); f) 80:1:19 TFA:triethylsilane:CH2Cl2, 5 mins, RT; g) Boc-Im-OH, DIEA, PyBOP, DMF, 60 ºC, 
microwave, 5 mins; h) Ac2O, DIEA, DMF, RT, 10 min; i) 80:1:19 TFA:triethylsilane:CH2Cl2, 25 mins, RT; j) 
Fmoc-D-Dab(Boc)-OH, DIEA, PyBOP, DMF, 60 ºC, microwave, 25 mins; k) Ac2O, DIEA, DMF, RT, 10 min; l) 
repeat b)-c) three times; m) 80:1:19 TFA:triethylsilane:CH2Cl2, 5 mins, RT; n) ImCCl3, DIEA, DMF, 60 ºC, 
microwave, 5 min; o) 20% piperidine / DMF, 60 ºC, microwave, 3 mins; p) Boc2O, DIEA, DMF, 60 ºC, 3 mins 
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Supporting Figure 2.  Trifluoroacetic acid deprotection conditions for resins 16–18.
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Supporting Figure 3.  Polyamide 12 was utilized to synthesize Mosher Amide conjugates 12-(R,R) and 12-(R,S).  
Polyamide 20 was synthesized by solid phase peptide synthesis on Kaiser oxime resin, using methods described in 
Belitsky, et al.1  It was prepared as a reference for comparing d.e. of 20-(R,R) to that of 12-(R,R). 
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Supporting Figure 4.  Resin 21 was prepared en route to 15.  Resin 22 was prepared prior to exchange of Fmoc for 
a Boc protecting group.  Compound 23 is the Fmoc-piperidine byproduct from Fmoc deprotection using 20% 
piperidine / DMF.  Polyamide 24 was a byproduct of Fmoc deprotection, present in approximately 0.4% yield. 
Polyamide 12-Boc was synthesized to evaluate whether full Fmoc removal had occurred prior to resin cleavage with 
Dp.  Presence of 12-Boc and absence of 12 would demonstrate full Fmoc removal by 20% piperidine / DMF. 
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Supporting Figure 5.  UPLC-MS data for stability of oxime resin to cleavage.  a) Resin 21 does not appear to 
cleave in the presence of HOBt, DIEA, and DMF at 60 ºC in the microwave for 25 min.  b) UPLC-MS data for 
extensive cleavage of resin 22 using 95% piperidine / DMF in microwave at 80 ºC for 20 min.  Two products of 
significance form: 23 (singly charged ion) and 24 (doubly charged ion).  c)  UPLC-MS data for 30 s exposure of 
resin 22 to 20% piperidine / DMF in the microwave at 60 ºC.  d)  UPLC-MS data for products resulting from Boc 
protection at the end of the reaction from part c).  Only polyamide 12-Boc, and not polyamide 12, forms.   
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Note: All compound and table numberings refer to those in the primary text.  Supporting information compounds 
contain numbers greater than those in the primary text. 
 
List of Reagents and Suppliers 
Reagent Vendor 
N,N-dimethylformamide (4L bottle) EMD Biosciences 
Oxime resin LL (100-200 mesh) EMD Biosciences 
PyBOP EMD Biosciences 
HPLC-grade dichloromethane Fluka 
Anhydrous diethyl ether Fluka 
Z-β-Dab(Boc)-OH Fluka 
(R)-(−)-α-Methoxy-α-(trifluoromethyl)phenylacetyl chloride Fluka 
(S)-(+)-α-Methoxy-α-(trifluoromethyl)phenylacetyl chloride Fluka 
Anhydrous methanol  Sigma-Aldrich 
HPLC-grade acetonitrile Sigma-Aldrich 
Trifluoroacetic acid (purified by redistillation, for protein Sigma-Aldrich 
 sequencing)       
Trifluoroacetic acid (ReagentPlus, 99%) Sigma-Aldrich 
Triethylsilane (99%) Sigma-Aldrich 
N,N-diisopropylethylamine (99%, redistilled) Sigma-Aldrich 
3,3’-Diamino-N-methyl-dipropylamine (96%) Sigma-Aldrich 
3-(Dimethylamino)-1-propylamine Sigma-Aldrich 
N-butylamine Sigma-Aldrich 
Piperidine (≥99%, redistilled) Sigma-Aldrich 
Di-tert-butyl dicarbonate (ReagentPlus, ≥99%) Sigma-Aldrich 
PyAOP Oakwood Chemicals 
Boc-β-Ala-OH Peptides International 
Boc-γ-Abu-OH Peptides International 
Fmoc-D-Dab(Boc)-OH Peptides International 
 
Boc-Py-OBt, Boc-Py-OH, Boc-Im-OH, Im-CCl3, and Ct-OH were prepared as described previously.2 
 
List of Instruments 
Microwave       Biotage Initiator Eight 
Analytical HPLC       Beckman Gold 
Semi-preparative HPLC      Agilent 1200 
Analytical UPLC       Agilent 1290 
MALDI-TOF MS      Voyager DE Pro 
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Resin Swelling, Washing, and Deswelling Procedures 
The coupling chemistries explored herein necessitate N,N-dimethylformamide (DMF), dichloromethane 
(DCM), and methanol (MeOH) wash steps.  The reactions are performed on 10 mg, 100 mg, and 1 g resin scales.  At 
the 10 mg scale, the resin was washed three times with 1 mL of each solvent (3 x 1 mL). At the 100 mg scale, each 
wash is 3 x 2 mL, and at the 1 g scale, each wash is 3 x 15 mL.  For each wash, the solid-phase synthesis vessel was 
agitated sufficiently to disperse the resin beads throughout the solvent.  Additionally, when switching solvents so as 
to swell or deswell the resin, the resin was allowed to soak in the solvent until a size change in the resin was 
observed.  Aside from these concerns, the length of each wash is not critical. 
 
Loading Boc-Py-OBt 
A 10–20 mL Biotage microwave synthesis vessel was charged with dry, deswollen Kaiser oxime resin (13, 1.2 
g, 1.02 mmol) (Supp. Fig. 1).  Boc-Py-OBt (1, 1.46 g, 4.08 mmol) was dissolved into 10 mL DMF and then added to 
13.  Diisopropylethylamine (DIEA, 711 µL, 4.08 mmol) and a stir bar were added prior to sealing the microwave 
vessel.  The vessel was placed into a Biotage Initiator Eight microwave synthesis machine and allowed to react for 3 
h at 80 ºC, 650 RPM, very high absorbance, FHT on.  The reaction vessel was opened, and resin was transferred as a 
slurry to a manual solid phase peptide synthesis vessel to drain the reagents from the resin.  The resin was washed 
with DMF and DCM, and then deswollen using MeOH.  The deswollen resin was dried in vacuo overnight, 
affording 1.56 g of 14, the loaded resin. 
The monomer Boc-Im-OH (2) can be loaded onto Kaiser oxime resin using the same conditions as for 1 but 
with the addition of 4 equivalents of PyBOP and the use of 8 equivalents of DIEA.  Subsequent couplings cleave the 
monomer from resin, rendering this loading impractical.  For applications necessitating a C-terminal Im monomer, 
the hydrazine resin is a reasonable alternative3 and can function using microwave chemistry. 
 
Optimization of Deprotection Time 
Resins 16, 17, and 18 (10 mg each) were swollen in manual solid phase synthesis vessels by washing with DMF 
and then CH2Cl2 (DCM).  The 80:1:19 TFA:triethylsilane (TES):DCM mix (1 mL) was added to the synthesis vessel 
and allowed to react for 5 min to 30 min, in 5 min intervals.  At each time point, the resin was washed with DCM, 
DMF, and then DCM.  Use of ReagentPlus® trifluoroacetic acid (Sigma-Aldrich Cat. No. T6508) afforded only 80-
90% deprotection over 25 min.  Exposure of resin to ReagentPlus® TFA for longer periods did not enable greater 
than 80-90% deprotection.  Use of protein sequencing grade, redistilled trifluoroacetic acid is essential to achieve 
full deprotection of the Boc-protected N-methylimidazole monomer. 
Over 99% deprotection, as determined by analytical HPLC, occurred in 5 min for 16→9 and 18→19.  The acid 
deprotection of Im monomer is known to take longer, and 25 min was sufficient for its deprotection (17→10) (Supp. 
Fig. 2). 
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Screening of Coupling Times 
Coupling times were screened using 20 mg (18.6 µmol) portions of dried, deswollen 9 or 10.  Tables 1 and 2 of 
the primary text provide number of equivalents of material utilized and final concentrations of the monomer with 
respect to total solution volume.  An example for coupling of 20 mg of resin 10 to monomer 1-OH in Table 2:  
Monomer 1-OH (17.9 mg, 74 µmol), PyAOP (38.6 mg, 74 µmol), DIEA (19.5 µL, 14.5 mg, 112 µmol), and 
DMF (227 µL) were added to a small glass vial and stirred to dissolve the monomer.  Resin 10, a stir bar, and the 
dissolved monomer 1-OH cocktail were added to a 2 mL Biotage microwave synthesis vessel.  The vessel was 
sealed, placed into the microwave synthesis machine, and allowed to react for 60 mins at 80 ºC (FHT on, very high 
absorbance). 
All other conditions in Tables 1 and 2 of the primary text are conducted analogously to that described in the 
example above, substituting appropriate numbers of equivalents, activating reagents, and coupling times as 
necessary.  All reactions, except those denoted by ‡ were run at 60 ºC.  Those containing ‡ were run at 80 ºC.  
Concentrations of monomers delineated in tables 1 and 2 should be increased if using pre-swollen resin.  In the case 
of the resin utilized here (EMD Biosciences Oxime resin LL 100-200 mesh Cat No. 855089), 0.4 M concentrations 
were sufficiently high to approximate the same final concentration of monomer. 
 S10	  
Detailed Synthesis of Polyamide 11 
Kaiser oxime resin (100 mg, 93 µmol) and Boc-Py-OBt (133 mg, 372 µmol, 4 eq.) were added to a 2 mL 
microwave synthesis vessel, along with a stir bar (Supp. Fig. 1).  DMF (1.24 mL) was added, and the mixture stirred 
until the Boc-Py-OBt was dissolved.  DIEA (64.8 µL, 372 µmol, 4 eq.) was added; the microwave synthesis vessel 
was then capped and heated in the microwave for 3 h (80 ºC, 650 RPM, FHT on, very high absorbance).  A manual 
solid-phase synthesis vessel was treated with Sigmacote and rinsed thoroughly; the reaction mixture was then 
transferred as a slurry to this vessel via a pipettor.  The resin was rinsed with DMF, DCM, and MeOH (according to 
the rinse procedure described earlier), then reswollen with DMF.  An aliquot of resin was removed and cleaved for 
HPLC analysis. 
The resin was rinsed with DCM.   The 80:1:19 TFA:TES:DCM deprotection cocktail (2 mL) was added to the 
resin, and the solid-phase synthesis vessel placed on a rocker at room temperature for 5 min.  The TFA solution was 
then drained, and the resin rinsed with DCM, DMF, and MeOH.  The resin was reswollen with DMF, and an aliquot 
was taken for HPLC analysis.  In a separate vial, Boc-Py-OBt (133 mg, 372 µmol, 4 eq.) and DIEA (32.4 µL, 186 
µmol, 2 eq.) were dissolved in DMF (930 µL), and the solution was added to the resin.  This mixture, along with a 
magnetic stir bar, was transferred to the microwave reaction vessel and heated for 5 min (60 ºC, 650 RPM, FHT on, 
very high absorbance).  The mixture was transferred back to the solid-phase synthesis vessel, and the resin rinsed 
with DMF, DCM, and MeOH.  The resin was reswollen with DMF, and an aliquot was taken for HPLC analysis.  
DMF (1.8 mL), DIEA (400 µL), and acetic anhydride (200 µL) were mixed in a vial, and the mixture added to the 
resin.  The resin was agitated on the rocker for 10 min at room temperature, then drained and rinsed with DMF and 
DCM. 
The above procedure was repeated to attach another Py monomer. 
The above procedure was repeated to attach an Im monomer, except that the mixture used for the coupling 
reaction comprised Boc-Im-OH (89.7 mg, 372 µmol, 4 eq.), PyBOP (194 mg, 372 µmol, 4 eq.), and DIEA (97.2 µL, 
558 µmol, 6 eq.) dissolved in DMF (930 µL). 
The above procedure was again used to attach the Fmoc-D-Dab(Boc)-OH turn monomer, with the following 
modifications: the resin was allowed to react with the deprotection solution for 25 min instead of 5 min, the coupling 
mixture comprised Fmoc-D-Dab(Boc)-OH (164 mg, 372 µmol, 4 eq.), PyBOP (194 mg, 372 µmol, 4 eq.), and DIEA 
(97.2 µL, 558 µmol, 6 eq.) dissolved in DMF (930 µL), and the coupling time was extended to 25 min. 
Following the addition of the turn, a slightly abbreviated procedure was used that omitted the acetyl capping 
step.  The resin was rinsed with DCM, then treated with the deprotection cocktail for 5 min.  The TFA solution was 
then drained, and the resin rinsed with DCM, DMF, and MeOH.  The resin was reswollen with DMF, and an aliquot 
was taken for HPLC analysis.  In a separate vial, Boc-Py-OBt (133 mg, 372 µmol, 4 eq.) and DIEA (32.4 µL, 186 
µmol, 2 eq.) were dissolved in DMF (930 µL), and the solution was added to the resin.  This mixture, along with a 
magnetic stir bar, was transferred to the microwave reaction vessel and heated for 5 min (60 ºC, 650 RPM, FHT on, 
very high absorbance).  The mixture was transferred back to the solid-phase synthesis vessel, and the resin rinsed 
with DMF, DCM, and MeOH.  The resin was reswollen with DMF, and an aliquot was taken for HPLC analysis. 
The above procedure was repeated two more times, to attach a further two Py monomers. 
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To attach the terminal Im monomer, the procedure was repeated again, with the Boc-Py-OBt replaced with Im-
CCl3 (84.6 mg, 372 µmol, 4 eq.). 
Piperidine (20% in DMF, 1 mL) was allowed to react with the resin in the microwave for 3 mins (60 ºC, 650 
RPM, FHT on, very high absorbance).  The resin was then returned to the solid phase synthesis vessel and rinsed 
with DMF, DCM, and MeOH, followed by reswelling in DMF.  The treatment with piperidine was repeated to 
ensure full deprotection.  Boc2O (203 mg, 930 µmol, 10 eq.) and DIEA (48.6 µL, 279 µmol, 3 eq.) were dissolved in 
DMF (1.86 mL) and added to the resin; the mixture was then transferred to the microwave synthesis vessel and 
microwaved for 3 mins (60 ºC, 650 RPM, FHT on, very high absorbance), affording resin 15.  Resin 15 was 
returned to the solid-phase synthesis vessel, drained, and rinsed with DMF, DCM, and MeOH before reswelling in 
DMF and taking an aliquot for HPLC analysis.  The resin was then deswollen in MeOH and dried in vacuo. 
For cleavage, an aliquot of 10 percent of the dry resin (15, 22 mg) was added to a solid-phase synthesis vessel 
and swollen with DMF.  3,3’-diamino-N-methyl-dipropylamine (500 µL) was added to the swollen resin, which was 
then transferred to a microwave synthesis vessel and heated for 10 mins (60 ºC, 650 RPM, FHT on, very high 
absorbance).  The reaction mixture was transferred back to the solid-phase synthesis vessel, and a further 500 µL 
DMF was used to rinse the microwave synthesis vessel.  The liquid (crude 11) was drained into a conical tube; resin 
15 was washed with a further 2 x 1 mL DMF, which was also collected in the conical tube.  Diethyl ether (30 mL) 
was added to the tube, which was then placed in a freezer at -20 ºC for 30 min.  The tube was then centrifuged at 
4200 RPM at 4 ºC for 30 min, and the supernatant removed.  The precipitate (crude 11) was suspended in 5 mL of 
0.1% TFA/H2O solution, and 1.0 N HCl in H2O was added at 0 ºC to reduce the pH to approximately 3.  This 
solution was then loaded directly onto the preparative HPLC. 
Following the HPLC run, the UV/Vis trace was examined, and the fractions corresponding to the major peak 
were further analyzed by analytical HPLC.  Fractions that showed only clean polyamide 11 with no contaminants 
were combined in a Falcon conical tube, frozen in liquid nitrogen, and lyophilized to dryness, affording a fluffy pale 
yellow solid.  This was centrifuged into a pellet, then dissolved in Gibco UltraPure distilled water.  An aliquot of 
this solution was serially diluted and analyzed by UV/Vis spectroscopy to quantify the yield (5.2 µmol, 56 %) of the 
polyamide (using a molar extinction coefficient of 69,500 M-1·cm-1).  A second aliquot was analyzed by MALDI-
TOF mass spectroscopy to confirm the identity of the product (expected [M+H]+: 1309.6, observed [M+H]+: 
1309.7). 
Compound 12 was prepared as described for 11, but no Boc-protection was performed after Fmoc removal.  
The resin sample was cleaved using dimethylaminopropylamine.  Compound 20 was synthesized using previously 
described methods.1,4  As with the synthesis of 12, for compound 20 no Boc-protection was performed at the end of 
the synthesis.  Cleavage was accomplished using dimethylaminopropylamine. 
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Notes on Maximizing Yield 
When an aliquot of resin-bound 15 was cleaved to give 11 and purified using a reversed-phase HPLC column 
that had not been thoroughly cleaned prior to use (but was in other respects identical to the one used to achieve 56% 
yield), isolated yield dropped to 44%. Additionally, larger aliquots (on the order of half of the cleavage eluent from 
a 100 mg resin scale batch) purified in one HPLC run resulted in a reduced yield of 46%.  It seems likely, therefore, 
that a significant amount of polyamide may be lost during purification, depending on the precise column conditions 
and loading. 
Polyamide 11 was also synthesized on a smaller scale, starting with 20 mg of Kaiser oxime resin (19 µmol).  
The methodology used was the same as described above; however, we were unable to achieve yields higher than 
21%.  This may be due to less efficient stirring in the smaller microwave reaction vessel, or it may be that the 
inevitable loss of small quantities of resin with each analytical HPLC aliquot and each transfer from solid-phase 
synthesis vessel to microwave vessel and back consumes a higher fraction of the resin on the smaller scale than on 
the larger.  Nevertheless, the amount of polyamide generated on this scale (4.0 µmol) is sufficient for initial 
biological experiments, so the lower yield may be acceptable in light of the savings in material cost when building a 
library of polyamides to test in cell culture experiments. 
 
Stability of Oxime Resin to General Coupling Conditions 
Because of the labile oxime-ester bond linking the growing Py-Im polyamide to the solid support, we checked 
whether the microwave conditions themselves would facilitate cleavage from resin.  To a 2 mL Biotage microwave 
vessel charged with 5 mg sample of resin 21 (Supp. Fig. 4) were added DMF (500 µL), DIEA (20 µL, 19.2 mg, 15 
µmol), HOBt (28 mg, 207 µmol), and a stirbar.  The vessel was sealed and allowed to react at 60 ºC, FHT on, very 
high absorbance in the microwave for 25 mins.  A sample of the supernatant (100 µL) was diluted using 0.1 % TFA 
/ H2O (400 µL), and a 2 µL sample was injected for analysis by UPLC-MS.  No cleavage products were observed 
containing a characteristic absorbance for a polyamide or a mass corresponding to products related to 21 (Supp Fig. 
5A). 
 
Stability of Oxime Resin to Fmoc Deprotection Conditions 
Because of the nucleophilicity of piperidine, we tested whether the Fmoc removal conditions would cause 
nucleophilic cleavage of the Py-Im polyamide from the solid support.  As a control reaction to demonstrate 
extensive cleavage by piperidine, a 2 mL microwave vessel was charged with resin 22 (5 mg), piperidine (480 µL), 
and DMF (20 µL) (Supp. Fig. 4).  The vessel was sealed and allowed to react at 80 ºC, FHT on, very high 
absorbance, for 20 min.  The supernatant of the reaction (100 µL) was diluted using 0.1 % TFA / H2O (400 µL), and 
a 2 µL sample was injected for analysis by UPLC-MS.  At a monitored absorbance of 254 nm, the areas of the peaks 
corresponding to 23 and 24 were 8699 and 8307, respectively (Supp. Fig. 5B). 
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To a 2 mL Biotage microwave vessel charged with 50 mg resin 22 (Supp. Fig. 4) were added DMF (800 µL) 
and piperidine (200 µL).  The vessel was sealed and allowed to react at 60 ºC, FHT on, very high absorbance in the 
microwave for 30 s.  A sample of the supernatant (50 µL) was diluted using 0.1 % TFA / H2O (450 µL; 1.0 N HCl 
was added dropwise to reduce the pH to solubilize material), and a 2 µL sample was injected for analysis by UPLC-
MS.  At a monitored absorbance of 254 nm, the areas of the peaks corresponding to 23 and 24 were 9621 and 35, 
respectively (Supp. Fig. 5C). 
Because resin cleavage with Dp will also cleave any remaining Fmoc on the polyamide, we chose to Boc 
protect the resin resulting from the previous 20% piperidine / DMF treatment.  The Boc protection will then give 
rise to only 12 or 12-Boc upon Dp cleavage, enabling the close approximation of the extent of Fmoc removal.  The 
remaining supernatant and resin were transferred to a manual solid phase synthesis vessel for washing with DMF, 
DCM, MeOH, and then DMF.  Boc2O (100 mg), DIEA (40 µL), and DMF (1 mL) were combined with the resin.  
The resin mixture and a stirbar were transferred to a microwave vessel, and the vessel was sealed.  The reaction 
proceeded at 60 ºC, FHT on, very high absorbance in the microwave for 5 min.  The resin was transferred into a 
manual synthesis vessel, and an aliquot was removed for Dp cleavage and UPLC-MS analysis.  We observed 
complete deprotection of the Fmoc under these conditions as measured by UPLC-MS (absence of compound 12 and 
presence of 12-Boc; Supp. Fig. 5D). 
We calculate that approximately 0.4% of the Py-Im polyamide on resin was nucleophilically cleaved from resin 
during 30 s, microwave-assisted Fmoc deprotection: 
%!"#$%$&# =    !"#!𝟐𝟒𝑺𝒂𝒎𝒑𝒍𝒆!"#!𝟐𝟑𝑺𝒂𝒎𝒑𝒍𝒆!"#!𝟐𝟒𝑪𝒕𝒍!"#!𝟐𝟑𝑪𝒕𝒍  Equation 1 
A one minute deprotection time in the microwave resulted in approximately 1.2% nucleophilic cleavage, and a three 
minute time resulted in approximately 3.4% nucleophilic cleavage.
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Alternate HPLC Sample Preparation Method 
In addition to the ether precipitation method described above, another method was used to prepare samples of 
cleaved polyamide for purification by HPLC.  In this method, the cleavage eluent was acidified to pH ~ 3 using 
1.0N HCl in H2O at 0 ºC, then loaded onto a Waters C18 Sep-Pak. 0.1% TFA was used to elute the excess cleavage 
agent.  The polyamide was eluted from the Sep-Pak with CH3CN, diluted with 0.1% TFA, lyophilized, and purified 
by semi-preparative HPLC.  Following purification, this method gave 52% yield, slightly lower than the yield 
obtained by the ether precipitation method. 
 
Preparation of Mosher Amides 
Polyamide 12 or 20 (100 nmol) was dissolved in anhydrous acetonitrile (500 µL), to which was added 
anhydrous DIEA (174 nL, 1 µmol, 10 eq.) and either the (R) or (S) Mosher acid chloride (93.5 nL, 500 nmol, 5 eq.).  
The DIEA and acid chloride were added as solutions in anhydrous acetonitrile to facilitate handling such small 
quantities of reagent.  The mixture was gently agitated for 30 min at room temperature, then diluted in 0.05 % 
TFA/H2O.  Conversion to the amide is virtually quantitative by analytical HPLC. 
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Analytical HPLC Characterization of Synthesis Intermediates 
Column: Phenomenex Gemini NX C18, 4.6 mm x 50 mm, 5 µm particle size, 110 Å pore size 
Instrument: Beckman Gold semi-preparative HPLC system 
Gradient: 5-95% CH3CN in 0.1% TFA/H2O over 7 mins at 1 mL / min. 
A minimal aliquot of DMF or DCM-washed and drained resin was removed from the peptide synthesis vessel 
using the tip of a Pasteur pipette and transferred to a microcentrifuge tube.  3-(Dimethylamino)-1-propylamine (Dp; 
150 µL) was added to the microcentrifuge tube containing resin.  If the resin-bound polyamide chain contained 
fewer than three monomers, N-butylamine was used in place of Dp to avoid formation of low molecular weight, 
doubly-cationic species, which have insufficient retention on the reversed-phase HPLC column.  The 
microcentrifuge tube was placed on a 95 ºC heat block for 5 mins.  Trifluoroacetic acid (TFA; 0.1% in H2O, 600 µL) 
was added to the microcentrifuge tube; the tube was vortexed and centrifuged briefly.  A 200 µL portion of the 
liquid phase in the microcentrifuge tube was utilized for HPLC.  Approximate yields are calculated by integrating 
the areas of starting material (areasm) and product peaks (areapdt) and calculating the ratio areapdt / (areapdt + areasm) at 
their local λmax, near 310 nm. 
 
Analytical UPLC Conditions for Separating Mosher Amide Diastereomers 
Column: Agilent 2.1 mm x 150 mm C18, 1.9 µm particle size 
Instrument: Agilent 1290 UPLC System 
Gradient: 28 – 32% CH3CN in 0.05% TFA/H2O over 36 mins at 0.6 mL / min. 
 
Analytical UPLC-MS Conditions 
Column: Agilent 2.1 mm x 50 mm C18, 1.9 µm particle size 
Instrument: Agilent 1290 UPLC System 
Gradient: 5 – 95% CH3CN in 0.1 N AcOH/H2O over 10 mins at 1.0 mL / min. 
 
Semi-Preparative HPLC Conditions 
Column: Phenomenex Gemini C18, 21 mm x 250 mm, 5 µm particle size, 110 Å pore size 
Instrument: Agilent 1200 HPLC System 
Gradient: 19-23% CH3CN in 0.1% TFA/H2O over 60 mins at 10 mL / min. 
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Mass Spectral Data of Compounds 
MALDI-TOF MS data 
11 (C62H81N22O11+): expected [M+H]+: 1309.6, observed [M+H]+: 1309.7 
12 (C55H68N21O9+): expected [M+H]+: 1166.6, observed [M+H]+: 1166.5 
12-(R,R) (C65H75F3N21O11+): expected [M+H]+: 1382.6, observed [M+H]+: 1382.7 
12-(R,S) (C65H75F3N21O11+): expected [M+H]+: 1382.6, observed [M+H]+: 1382.6 
20 (C55H68N21O9+): expected [M+H]+: 1166.6, observed [M+H]+: 1166.5 
20-(R,R) (C65H75F3N21O11+): expected [M+H]+: 1382.6, observed [M+H]+: 1382.7 
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Analytical HPLC UV/Vis trace, compound 11, 314 nm. 
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MALDI-TOF spectrum, compound 11.
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Analytical HPLC UV/Vis trace, compound 12, 314 nm. 
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MALDI-TOF spectrum, compound 12. 
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Analytical HPLC UV/Vis trace, compound 12-(R,R), 314 nm. 
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MALDI-TOF spectrum, compound 12-(R,R). 
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Analytical HPLC UV/Vis trace, compound 12-(R,S), 314 nm. 
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MALDI-TOF spectrum, compound 12-(R,S). 
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Analytical HPLC UV/Vis trace, compound 20, 314 nm. 
M
in
ut
es
0
5
10
15
mAU (Abs at 314 nm)
0
10
00
20
00
010
00
20
00
20
NN
N H
O
N
N H
O
N
N H
O
N
NH
O
(R
)
H N
O
NH
3
N N
H N
O
N
H N
O
N
O
H N
N
O
H N
N H
 S26	  
 
MALDI-TOF spectrum, compound 20. 
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Analytical HPLC UV/Vis trace, compound 20-(R,R), 314 nm. 
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MALDI-TOF spectrum, compound 20-(R,R). 
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Analytical UPLC traces from Mosher amide derivatization experiment. 
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